AG
MYGN icon

Algert Global’s Myriad Genetics MYGN Stock Holding History

Algert Global’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.64M Sell
363,822
-1,635
-0.4% -$8.52K 0.02% 756
2025
Q4 		$2.25M Sell
365,457
-547,608
-60% -$3.97M 0.04% 682
2025
Q3 		$6.6M Buy
+913,065
New +$5.42M 0.11% 321
2025
Q2 		– Sell
-180,548
Closed -$1.6M – 1287
2025
Q1 		$1.6M Buy
180,548
+120,450
+200% +$1.45M 0.04% 667
2024
Q4 		$824K Buy
60,098
+38,818
+182% +$716K 0.02% 824
2024
Q3 		$583K Buy
21,280
+12,232
+135% +$331K 0.02% 871
2024
Q2 		$221K Buy
+9,048
New +$199K 0.01% 1247
2014
Q2 		– Sell
-9,950
Closed -$340K – 330
2014
Q1 		$340K Sell
9,950
-4,200
-30% -$130K 0.13% 222
2013
Q4 		$297K Buy
+14,150
New +$358K 0.08% 286

Other funds holding MYGN

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.69B AUM 20.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return